-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Upgrades Abbott Laboratories to Outperform, Announces $130 Price Target

Benzinga·08/13/2026 17:13:03
Listen to the news
Wolfe Research analyst Mike Polark upgrades Abbott Laboratories (NYSE:ABT) from Peer Perform to Outperform and announces $130 price target.